Who Buys Tamoxifen from India — 377 Importers Behind a $14.7M Market
India's tamoxifen import market is served by 377 active buyers who collectively imported $14.7M across 3,139 shipments. AUROBINDO PHARMA USA., INC, (UNITED STATES) leads with a 17.2% market share, followed by ALIUD PHARMA GMBH and AUROBINDO PHARMA USA INC. The top 5 buyers together control 48.8% of total import value, reflecting a moderately competitive buyer landscape.
Tamoxifen buyer data — 377 importers · $14.7M market · 3,139 shipmentsTransData Nexus · Indian Customs Data
Top Tamoxifen Importers — Ranked by Import Value
AUROBINDO PHARMA USA., INC, (UNITED STATES) is the leading tamoxifen importer from India, holding a 17.2% share of the $14.7M market across 3,139 shipments from 377 buyers. The top 5 buyers — AUROBINDO PHARMA USA., INC, (UNITED STATES), ALIUD PHARMA GMBH (GERMANY), AUROBINDO PHARMA USA INC (UNITED STATES), AUROLOGISTICS LLC, (AUROBINDO PHARM (UNITED STATES), BELLS HEALTHCARE (UNITED KINGDOM) — collectively control 48.8% of total import value.
Top Tamoxifen Buyers & Importers
Ranked by import value · 377 active buyers · Indian Customs (DGFT) data
Mar 2026
Top Tamoxifen Buyers & Importers — Ranked by Import Value. 377 active buyers with import value, shipments, country and supplier data compiled from Indian Customs records by TransData Nexus.
Which companies are buying Tamoxifen — and from which countries?
Flow of Tamoxifen exports from India: each country's share and the named importers behind the numbers
Tamoxifen — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Top 5 importing countries account for 92.4% of global Tamoxifen imports — led by United States (42.5%) with a total trade value of $14.7M across 3,139 shipments from India.
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $6.3M through 155 shipments. This represents a market share of 42.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• AUROBINDO PHARMA USA., INC, - $2.5M (40.4% of country's total business)
• AUROBINDO PHARMA USA INC - $1.2M (18.9% of country's total business)
• AUROLOGISTICS LLC, (AUROBINDO PHARM - $1.2M (18.9% of country's total business)
• AUROBINDO PHARMA USA.INC.,. - $400.9K (6.4% of country's total business)
• AUROBINDO PHARMA USA., INC - $351.2K (5.6% of country's total business)
• Rest of United States's importers - $613.6K (9.8% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $40.4K, indicating premium pricing strategy compared to the market average of $4.7K.
United States is a key market for Tamoxifen imports, representing 42.5% of total trade value.
The importation of Tamoxifen from India involves various buyer segments, each with distinct purchasing behaviors:
Distributors: Entities like ALIUD PHARMA GMBH in Germany and BELLS HEALTHCARE in the United Kingdom function as intermediaries, procuring Tamoxifen in bulk to supply to pharmacies, hospitals, and clinics. Their purchasing patterns are characterized by large, regular orders to maintain a steady supply chain.
Contract Manufacturers: Companies such as AUROBINDO PHARMA USA., INC and AUROLOGISTICS LLC in the United States import Tamoxifen for further processing or packaging before distribution. Their procurement is aligned with production schedules, leading to sizable, periodic orders.
Retail Chains: Organizations like WOCKHARDT UK LIMITED and TILLOMED LABORATORIES LIMITED in the United Kingdom import Tamoxifen to stock their retail outlets. Their purchasing behavior is influenced by consumer demand, resulting in moderate, consistent orders to ensure product availability.
Government Procurement: While not explicitly listed among the top buyers, government agencies and international organizations often engage in tender-based purchasing of essential medicines like Tamoxifen. Their procurement processes are typically large-scale and periodic, driven by public health initiatives and budget cycles.
Importing Tamoxifen into the top five countries involves navigating specific regulatory frameworks:
United States:
Regulatory Authority: Food and Drug Administration (FDA).
Import Registration Process: Importers must ensure that Tamoxifen is FDA-approved and comply with the Drug Supply Chain Security Act (DSCSA).
Estimated Timeline: The FDA approval process can take several months, depending on the completeness of the application and compliance with regulatory requirements.
Import Tariff/Duty: Pharmaceutical products under HS Code 30049048 are generally duty-free, but importers should verify current tariffs with U.S. Customs and Border Protection.
Germany:
Regulatory Authority: Federal Institute for Drugs and Medical Devices (BfArM).
The demand for Tamoxifen across importing countries is influenced by several key factors:
Disease Prevalence: Tamoxifen is primarily used in the treatment and prevention of breast cancer. According to the World Health Organization (WHO), breast cancer remains the most common cancer among women worldwide, with approximately 2.3 million new cases diagnosed in 2025. This high prevalence drives consistent demand for effective treatments like Tamoxifen.
Government Healthcare Programs: Many countries have implemented national health programs that subsidize or provide essential medicines to their populations. For instance, the United Kingdom's National Health Service (NHS) includes Tamoxifen in its formulary, ensuring widespread access.
Universal Health Coverage Expansion: Countries expanding their universal health coverage are increasing access to essential medicines. Thailand's Universal Coverage Scheme, for example, has improved access to cancer treatments, including Tamoxifen, for its citizens.
WHO Essential Medicines List Procurement: Tamoxifen is listed on the WHO Model List of Essential Medicines, guiding countries in prioritizing procurement. This inclusion encourages governments and health organizations to stock Tamoxifen, ensuring its availability in public health systems.
Common Questions — Tamoxifen Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest tamoxifen buyer importing from India?
Based on import volume and value, AUROBINDO PHARMA USA., INC, (UNITED STATES) leads with $2.5M in imports and a 17.2% market share — the highest of any single tamoxifen importer. ALIUD PHARMA GMBH (GERMANY) and AUROBINDO PHARMA USA INC (UNITED STATES) are the next largest buyers.
QHow many companies buy tamoxifen from India?
There are 377 active tamoxifen buyers importing from India, with a combined market of $14.7M across 3,139 shipments to 104 countries. The top 5 buyers hold 48.8% of total import value, while the remaining 372 buyers handle the other 51.2%.
QWhich countries import the most tamoxifen from India?
The top importing countries for tamoxifen from India are United States (42.5%), Germany (24.0%), United Kingdom (11.1%), Belgium (7.9%), Thailand (6.9%). These markets represent the largest demand centres for Indian pharmaceutical exports of tamoxifen, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for tamoxifen from India?
The average import transaction value for tamoxifen from India is $4.7K, with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
The importation of Tamoxifen from India involves various buyer segments, each with distinct purchasing behaviors:
Distributors: Entities like ALIUD PHARMA GMBH in Germany and BELLS HEALTHCARE in the United Kingdom function as intermediaries, procuring Tamoxifen in bulk to supply to pharmacies, hospitals, and clinics. Their purchasing patterns are characterized by large, regular orders to maintain a steady supply chain.
Contract Manufacturers: Companies such as AUROBINDO PHARMA USA., INC and AUROLOGISTICS LLC in the United States import Tamoxifen for further processing or packaging before distribution. Their procurement is aligned with production schedules, leading to sizable, periodic orders.
Retail Chains: Organizations like WOCKHARDT UK LIMITED and TILLOMED LABORATORIES LIMITED in the United Kingdom import Tamoxifen to stock their retail outlets. Their purchasing behavior is influenced by consumer demand, resulting in moderate, consistent orders to ensure product availability.
Government Procurement: While not explicitly listed among the top buyers, government agencies and international organizations often engage in tender-based purchasing of essential medicines like Tamoxifen. Their procurement processes are typically large-scale and periodic, driven by public health initiatives and budget cycles.
Importing Tamoxifen into the top five countries involves navigating specific regulatory frameworks:
United States:
Regulatory Authority: Food and Drug Administration (FDA).
Import Registration Process: Importers must ensure that Tamoxifen is FDA-approved and comply with the Drug Supply Chain Security Act (DSCSA).
Estimated Timeline: The FDA approval process can take several months, depending on the completeness of the application and compliance with regulatory requirements.
Import Tariff/Duty: Pharmaceutical products under HS Code 30049048 are generally duty-free, but importers should verify current tariffs with U.S. Customs and Border Protection.
Germany:
Regulatory Authority: Federal Institute for Drugs and Medical Devices (BfArM).
The demand for Tamoxifen across importing countries is influenced by several key factors:
Disease Prevalence: Tamoxifen is primarily used in the treatment and prevention of breast cancer. According to the World Health Organization (WHO), breast cancer remains the most common cancer among women worldwide, with approximately 2.3 million new cases diagnosed in 2025. This high prevalence drives consistent demand for effective treatments like Tamoxifen.
Government Healthcare Programs: Many countries have implemented national health programs that subsidize or provide essential medicines to their populations. For instance, the United Kingdom's National Health Service (NHS) includes Tamoxifen in its formulary, ensuring widespread access.
Universal Health Coverage Expansion: Countries expanding their universal health coverage are increasing access to essential medicines. Thailand's Universal Coverage Scheme, for example, has improved access to cancer treatments, including Tamoxifen, for its citizens.
WHO Essential Medicines List Procurement: Tamoxifen is listed on the WHO Model List of Essential Medicines, guiding countries in prioritizing procurement. This inclusion encourages governments and health organizations to stock Tamoxifen, ensuring its availability in public health systems.
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
2Germany
Germany emerges as the second largest importing country, achieving a total trade value of $3.5M through 25 shipments. This represents a market share of 24.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Germany has a diverse importer base, with their top importers including:
• ALIUD PHARMA GMBH - $1.9M (52.9% of country's total business)
Key Insight: Germany demonstrates strong market positioning with an average shipment value of $141.2K, indicating premium pricing strategy compared to the market average of $4.7K.
Germany is a key market for Tamoxifen imports, representing 24.0% of total trade value.
Primary Market
Secondary Market
3United Kingdom
United Kingdom emerges as the third largest importing country, achieving a total trade value of $1.6M through 41 shipments. This represents a market share of 11.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United Kingdom has a diverse importer base, with their top importers including:
• BELLS HEALTHCARE - $416.4K (25.5% of country's total business)
• WOCKHARDT UK LIMITED - $409.8K (25.1% of country's total business)
• TILLOMED LABORATORIES LIMITED - $404.1K (24.7% of country's total business)
• MILPHARM LIMITED, - $101.0K (6.2% of country's total business)
Key Insight: United Kingdom demonstrates strong market positioning with an average shipment value of $39.8K, indicating premium pricing strategy compared to the market average of $4.7K.
United Kingdom is a key market for Tamoxifen imports, representing 11.1% of total trade value.
Primary Market
Secondary Market
4Belgium
Belgium emerges as the fourth largest importing country, achieving a total trade value of $1.2M through 0 shipments. This represents a market share of 7.9% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Belgium demonstrates strong market positioning with an average shipment value of $1.2M, indicating premium pricing strategy compared to the market average of $4.7K.
Belgium is a key market for Tamoxifen imports, representing 7.9% of total trade value.
Primary Market
Secondary Market
5Thailand
Thailand emerges as the fifth largest importing country, achieving a total trade value of $1.0M through 18 shipments. This represents a market share of 6.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Thailand has a diverse importer base, with their top importers including:
• PIPHLPT - $212.7K (20.9% of country's total business)
• TMBTHANACHART BANKPUBLIC CO LTD - $115.0K (11.3% of country's total business)
• TMBTHANACHART BANK - $115.0K (11.3% of country's total business)
Key Insight: Thailand demonstrates strong market positioning with an average shipment value of $56.6K, indicating premium pricing strategy compared to the market average of $4.7K.
Thailand is a key market for Tamoxifen imports, representing 6.9% of total trade value.
Primary Market
Secondary Market
Re-exporters: Some buyers may import Tamoxifen with the intent to re-export to other markets. This segment's purchasing behavior is opportunistic, capitalizing on price differentials and market demands in various regions.
Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Import Registration Process: Tamoxifen must be registered with BfArM, and importers need a wholesale license.
Estimated Timeline: Registration can take several months, contingent on the submission of required documentation and compliance with EU regulations.
Import Tariff/Duty: As an EU member, Germany applies the Common External Tariff, which may impose duties on pharmaceuticals; importers should consult the latest EU tariff schedules.
United Kingdom:
Regulatory Authority: Medicines and Healthcare products Regulatory Agency (MHRA).
Import Registration Process: Importers must hold a Wholesale Dealer's License and ensure Tamoxifen is registered with the MHRA.
Estimated Timeline: The registration process can take several months, depending on the complexity of the application and compliance with UK regulations.
Import Tariff/Duty: Post-Brexit, the UK sets its own tariffs; importers should refer to the UK Global Tariff for current rates on HS Code 30049048.
Belgium:
Regulatory Authority: Federal Agency for Medicines and Health Products (FAMHP).
Import Registration Process: Tamoxifen must be authorized by FAMHP, and importers require a distribution license.
Estimated Timeline: Authorization can take several months, subject to the provision of necessary documentation and adherence to EU directives.
Import Tariff/Duty: As part of the EU, Belgium applies the Common External Tariff; importers should check the latest EU tariff information for pharmaceuticals.
Thailand:
Regulatory Authority: Thai Food and Drug Administration (Thai FDA).
Import Registration Process: Importers must obtain a license from the Thai FDA, and Tamoxifen must be registered before importation.
Estimated Timeline: The registration process can take several months, depending on the completeness of the application and compliance with Thai regulations.
Import Tariff/Duty: Thailand imposes import duties on pharmaceuticals; importers should consult the Thai Customs Department for current rates on HS Code 30049048.
Importers are advised to consult the respective regulatory authorities and customs departments for the most current and detailed information, as regulations and tariffs are subject to change.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Tender-Based Purchasing: Many governments and large healthcare providers procure medicines through tender processes to ensure cost-effectiveness and supply security. The WHO emphasizes the importance of tendering and negotiation in pharmaceutical procurement to achieve lower prices and reliable supply chains. (iris.who.int)
With 377 buyers across 104 countries, the global market for Tamoxifen is robust. The combination of high disease prevalence, supportive government policies, and strategic procurement practices presents significant market opportunities for suppliers.
TransData Nexus Research · Government and regulatory sourcesMar 2026
$3.83 per unit
Re-exporters: Some buyers may import Tamoxifen with the intent to re-export to other markets. This segment's purchasing behavior is opportunistic, capitalizing on price differentials and market demands in various regions.
Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Import Registration Process: Tamoxifen must be registered with BfArM, and importers need a wholesale license.
Estimated Timeline: Registration can take several months, contingent on the submission of required documentation and compliance with EU regulations.
Import Tariff/Duty: As an EU member, Germany applies the Common External Tariff, which may impose duties on pharmaceuticals; importers should consult the latest EU tariff schedules.
United Kingdom:
Regulatory Authority: Medicines and Healthcare products Regulatory Agency (MHRA).
Import Registration Process: Importers must hold a Wholesale Dealer's License and ensure Tamoxifen is registered with the MHRA.
Estimated Timeline: The registration process can take several months, depending on the complexity of the application and compliance with UK regulations.
Import Tariff/Duty: Post-Brexit, the UK sets its own tariffs; importers should refer to the UK Global Tariff for current rates on HS Code 30049048.
Belgium:
Regulatory Authority: Federal Agency for Medicines and Health Products (FAMHP).
Import Registration Process: Tamoxifen must be authorized by FAMHP, and importers require a distribution license.
Estimated Timeline: Authorization can take several months, subject to the provision of necessary documentation and adherence to EU directives.
Import Tariff/Duty: As part of the EU, Belgium applies the Common External Tariff; importers should check the latest EU tariff information for pharmaceuticals.
Thailand:
Regulatory Authority: Thai Food and Drug Administration (Thai FDA).
Import Registration Process: Importers must obtain a license from the Thai FDA, and Tamoxifen must be registered before importation.
Estimated Timeline: The registration process can take several months, depending on the completeness of the application and compliance with Thai regulations.
Import Tariff/Duty: Thailand imposes import duties on pharmaceuticals; importers should consult the Thai Customs Department for current rates on HS Code 30049048.
Importers are advised to consult the respective regulatory authorities and customs departments for the most current and detailed information, as regulations and tariffs are subject to change.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Tender-Based Purchasing: Many governments and large healthcare providers procure medicines through tender processes to ensure cost-effectiveness and supply security. The WHO emphasizes the importance of tendering and negotiation in pharmaceutical procurement to achieve lower prices and reliable supply chains. (iris.who.int)
With 377 buyers across 104 countries, the global market for Tamoxifen is robust. The combination of high disease prevalence, supportive government policies, and strategic procurement practices presents significant market opportunities for suppliers.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Analysis Methodology
1.Buyer Identification: 377 global importers of Tamoxifen identified from consignee fields in DGFT shipping bill records.
2.Import Value Analysis: Total import value aggregated from 3,139 individual shipping bill records. Values are FOB in USD.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
4.Geographic Distribution: Buyer imports distributed across 104 destination countries with market share per buyer calculated from capped values.
